Press release
Poultry Vaccines Market Expected to Exceed USD 8.1 Billion by 2031 as Biosecurity, Sustainability, and Recombinant Technologies Influence Global Immunization Programs
Request Sample @ https://clearviewmarketinsights.com/report-details/global-poultry-vaccines-market/
2024 Industry Milestones:
Hatchery Vaccine Automation Expands in Asia and LATAM
• Ceva is installing over 150 automated in ovo and spray stations in India, Brazil, and Vietnam.
mRNA Vaccines Enter Pilot Trials
• U.S. and EU veterinary companies initiate trials for rapid-response avian influenza mRNA vaccine platforms
Multivalent Combo Vaccines Reduce Labor Costs
• Zoetis introduces Poulvac® Combo ND + IBD + IB in single dose format
Executive Insights:
"Vaccination is no longer an option-it's a prerequisite for scale, trust, and resilience in poultry systems," said Dr. Mikkel Johansson, Global Poultry Vaccine Lead, Clearview Market Insights.
"Recombinant vaccines, delivered in ovo or via spray, are now frontline tools in the fight against zoonoses and productivity loss," added Marta Alvarez, Technical Director, MSD Animal Health.
Roadmap to 2031:
• 2025: Recombinant vaccines comprise 25% of the total poultry vaccine market.
• 2026: Blockchain-based vaccine records connected to traceability platforms in the EU and ASEAN.
• 2028: AI-based vaccine demand forecasting and inventory systems are operational in major hatcheries.
• 2030: Thermostable vaccines replace cold chain-reliant doses in 60+ countries
• 2031: mRNA vaccines commercialized for fast-mutating avian strains
For more insights, visit https://clearviewmarketinsights.com/
Media contact:
Bhavani K
Marketing and Sales Head
ClearView Market Insights
Mail: sales@clearviewmarketinsights.com
Phone: +1 917-993-7369
About Clearview Market Insights
Clearview Market Insights offers in-depth research on poultry health, disease prevention, and vaccine innovation. Our insights support hatcheries, integrators, and pharmaceutical leaders in developing safe, productive, and sustainable poultry systems.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Poultry Vaccines Market Expected to Exceed USD 8.1 Billion by 2031 as Biosecurity, Sustainability, and Recombinant Technologies Influence Global Immunization Programs here
News-ID: 4036369 • Views: …
More Releases from ClearView Market Insights
Global Clamps Market to Reach USD 7.4 Billion by 2031, Driven by Industrial Grow …
[London, 6 November 2025] - Clearview Market Insights (CVMI) predicts that the global clamps market will rise from USD 5.1 billion in 2024 to USD 7.4 billion in 2031, with a CAGR of 5.4%. Growth is driven by increasing industrial activity, expansion in construction, and greater adoption in automotive and medical sectors.
"Clamps are essential tools across industries, ensuring precision, safety, and efficiency in both manufacturing and healthcare applications," said…
Global Circulating Tumor Cells Market to Reach USD 12.6 Billion by 2031, Driven …
[Boston, 5 October 2025] - Clearview Market Insights (CVMI) predicts that the global circulating tumor cells market will increase from USD 5.4 billion in 2024 to USD 12.6 billion by 2031, with a compound annual growth rate of 12.7%. The growth is fueled by the demand for minimally invasive cancer diagnostics and the expanding role of CTCs in personalized treatment approaches.
Request Sample: https://clearviewmarketinsights.com/report-details/global-circulating-tumor-cells-market/
"Circulating tumor cell analysis is redefining cancer…
Global Cerebrospinal Fluid (CSF) Management Market to Reach USD 5.39 Billion by …
[London, 04 October 2025] - Clearview Market Insights (CVMI) forecasts that the global cerebrospinal fluid (CSF) management market will increase from USD 2.43 billion in 2024 to USD 5.39 billion by 2031, with a compound annual growth rate (CAGR) of 12.1%. Rising neurological disorder rates, aging populations, and innovations in neurocritical care technologies are driving market expansion.
Request Sample: https://clearviewmarketinsights.com/report-details/global-cerebrospinal-fluid-management-market/
"Modern CSF management solutions are transforming the treatment landscape for hydrocephalus,…
Global Chromatography Syringe Market to Reach USD 1.96 Billion by 2031, Driven b …
[Chicago, 08 October 2025] - Clearview Market Insights (CVMI) predicts that the global chromatography syringe market will increase from USD 1.03 billion in 2024 to USD 1.96 billion by 2031, with a CAGR of 9.5%. The rising demand is due to growing pharmaceutical research, food safety testing, and environmental monitoring.
"Chromatography syringes are the backbone of precise analytical testing, ensuring accuracy and reliability in industries where quality matters most," said…
More Releases for Vaccine
Adult Vaccines Market By Type (Preventive Vaccine, Therapeutic Vaccine)
Global Adult Vaccines Market 2022 Research Report initially provides a basic overview of the industry that covers definition, applications and manufacturing technology, post which the report explores into the international players in the market.
Download Sample PDF at https://www.theinsightpartners.com/sample/TIPRE00007244/?utm_source=OpenPR&utm_medium=10379
Key Players Analysis:
AstraZeneca
Bharat Biotech
Dynavax Technologies Corporation
GlaxoSmithKline
Johnson & Johnson
Merck and Co
Novartis
Pfizer
Sanofi Pasteur
Serum Institute of India
The report covers key developments in the Adult Vaccines market as organic and inorganic growth strategies. Various companies are focusing…
Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market…
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market.
Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top…
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze…
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025
Measles Vaccine Market Production and Demand Analysis 2019 to 2025
Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025
Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025
Measles Vaccine Market to Insight By 2025: Top Key Vendors
The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by the…
Monovalent vaccine segment to accumulate maximum Paediatric Vaccine Market share
According to a new report published by Future Market Insights titled “Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 – 2026”, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016.
Paediatric vaccine market is a billion dollar market accounting for a substantial proportion…
